Actelion Pharmaceuticals Ltd / Invitation to discuss Actelion's nine months results 2016 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Dear member of the investment community,

Actelion Ltd will announce its financial results for the first nine months of 2016 on Thursday, 20 October 2016, at 07:00 hrs CEST.


An investor conference call and webcast will be held at 13:00 hrs CEST to discuss the results.

To support your preparations, consensus estimates can be found under www.actelion.com/consensus-estimate

Date/Time:  

   
20 October 2016 13:00 hrs - 14:00 hrs Basel
  12:00 hrs - 13:00 hrs London
  07:00 hrs - 08:00 hrs New York

  
Conference Call Connect #:
Dial-in participants should start calling the number below 10-15 minutes before the conference is due to start.

Dial: Europe: +41 (0)44 583 18 01
  UK: +44 (0)203 009 24 60
  US: +1 855 402 77 67

Participant's mode:
Listen-Only with possibility to open individual lines during Q&A session. Participants will be asked for their name and company.

Webcast Access:
Webcast participants should go to the Actelion website http://www.actelion.com 10-15 minutes before the conference is due to start.

Participant's mode: Listen-Only

Webcast Replay:

The archived Investor Webcast will be available for replay through http://www.actelion.com/  approximately 60 minutes after the call has ended.

Invitation Conference Call/Webcast PDF


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Globenewswire

--- End of Message ---

Actelion Pharmaceuticals Ltd
Gewerbestrasse 16 Allschwil Switzerland

ISIN: CH0010532478;